A Study of PM1022 in Patients With Advanced Tumors
NCT05867771
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Tumors
Interventions
DRUG:
PM1022
Sponsor
Biotheus Inc.